Dengue Testing Market Trends

Statistics for the 2023 & 2024 Dengue Testing market trends, created by Mordor Intelligence™ Industry Reports. Dengue Testing trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Dengue Testing Industry

This section covers the major market trends shaping the Dengue Testing Market according to our research experts:

The ELISA-based Tests Segment is Anticipated to Hold a Significant Share of the Market

The ELISA-based tests segment is anticipated to hold a significant market share owing to factors such as the increasing incidence of dengue cases and the growing adoption of ELISA-based dengue testing.

Enzyme-linked immunosorbent assay (ELISA) is one of the most common and widely accepted methods for diagnosing dengue. The test measures the presence of anti-DENV IgM or IgG antibodies in the patient's serum. The early and timely diagnosis and management of dengue can reduce the risk of morbidity and mortality rates from severe forms of dengue disease and decrease the risk of wider outbreaks.

ELISA, the standard method, can detect NS1 antigens and differentiate between the four dengue virus serotypes. Thus, the use of ELISA for dengue testing is expected to increase over the forecast period. For instance, in February, the Health Department in India issued directions to private labs and hospitals to get only ELISA confirmatory tests done at government labs, due to which private labs were asked to send samples for the ELISA test if patients test positive for dengue through other initial tests.

Furthermore, a research study published in November of the base year showed that ANS1-based DENV IgG ELISA conferred enhanced diagnostic specificity for anti-DENV serological tests and may be particularly useful for serological analyses in endemic regions for DENV and ZIKV transmission. Thus, using ELISA-based tests for dengue is expected to increase over the years and boost the market's growth.

Moreover, technological advancements in ELISA platforms, such as complete test kits offered by several major players, contribute to the market's growth. For instance, Panbio Dengue IGG Indirect ELISA, a test kit provided by Abbott, is used to detect IgG antibodies to dengue antigen serotypes (1, 2, 3, and 4) in serum as an aid to the clinical laboratory diagnosis of patients with clinical symptoms and past exposure consistent with dengue fever.

Thus, considering all the factors mentioned above, the segment is expected to witness steady growth over the forecast period.

Dengue Testing Market: Cumulative Incidence Rates of Dengue (Per 100,000 Population), Americas, 2021

Asia-Pacific is the Fastest Growing Region in the Dengue Testing Market

Asia-Pacific is expected to be the fastest-growing region in the dengue testing market over the forecast period.

The increasing prevalence of disease infections within the region contributes to the market's growth. For instance, as per the data published by the ECDC, approximately 313 cases in Indonesia, 816 cases in Sri Lanka, 1,286 cases in Timor-Leste, and 2,440 cases in Vietnam were reported. Additionally, as per NCVBDC, the number of dengue cases in India increased from 44,585 cases to 193,245 in the base year. A large number of dengue cases in the region, necessitating the requirement of testing, is expected to boost the growth of the dengue testing market.

According to WHO data, 17,497 dengue cases were reported in Malaysia in the Western Pacific region. The registered number reflected a 57.6% increase compared to the same period in the base year. The increasing number of dengue cases in the area will likely propel the growth of the dengue testing market over the forecast period.

Furthermore, an article published about the diagnostic challenges in detecting dengue in COVID-19-affected people showed a correlation between COVID-19 and the dengue virus infection, as the patients were reactive to both tests, indicating a cross-reactivity. This indicated a public health concern in detecting COVID-19 infection in dengue-endemic countries.

Similarly, a study published in April of the base year that compared the accuracy and efficacy of six rapid diagnostic kits available for dengue viral detection in Singapore observed that Standard Q had the highest degree of sensitivity and specificity in detecting dengue virus infection. The kit could be used for efficient dengue disease surveillance. The rise in the necessity of such diagnostic kits, owing to the high sensitivity, is likely to add to the market's growth over the forecast period.

Moreover, such outbreaks across various regions in Asia-Pacific led several companies to develop dengue diagnostic test kits, contributing to the market's growth over the forecast period. For instance, in November of the base year, Achiko initiated the development of a dengue fever diagnostic test by applying its DNA aptamer technology platform.

The initiatives taken by the government to spread dengue awareness among the population are expected to fuel the market's growth. For instance, in May this year, the National Dengue Control Unit of Sri Lanka organized a mosquito control program from 18 May to 24 May in risky and high-risk areas in 20 districts to control the spread of dengue.

Thus, the market is expected to project growth over the forecast period due to the abovementioned factors.

Dengue Testing Market- Growth Rate by Region

Dengue Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)